Similar articles for PMID: 34493565

Year	Number of Results
2015	3
2016	20
2017	16
2018	16
2019	21
2020	22
2021	30
2022	30
2023	7
2024	0

1

Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.

Shamchuk A, Doulla M, Jetha M. Shamchuk A, et al. CMAJ. 2021 Sep 7;193(35):E1385-E1388. doi: 10.1503/cmaj.202627. CMAJ. 2021. PMID: 34493565 Free PMC article. No abstract available.

2

Association possible entre l’acidocétose diabétique et l’utilisation d’un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabète de type 2.

Shamchuk A, Doulla M, Jetha M. Shamchuk A, et al. CMAJ. 2021 Nov 15;193(45):E1746-E1749. doi: 10.1503/cmaj.202627-f. CMAJ. 2021. PMID: 34782384 Free PMC article. French. No abstract available.

3

SGLT2 Inhibitors and Euglycemic Ketoacidosis.

Masuta P, Johri G, Paul M. Masuta P, et al. Am J Ther. 2018 Jul/Aug;25(4):e498-e500. doi: 10.1097/MJT.0000000000000587. Am J Ther. 2018. PMID: 28537992 No abstract available.

4

[Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation].

Moreno Obregón F, Espino Montoro A, Marín Martín J, León Jiménez D. Moreno Obregón F, et al. Aten Primaria. 2019 Dec;51(10):664-666. doi: 10.1016/j.aprim.2019.04.007. Epub 2019 Jul 17. Aten Primaria. 2019. PMID: 31326123 Free PMC article. Spanish. No abstract available.

5

Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.

Koch RA, Clark RF. Koch RA, et al. Am J Ther. 2018 Sep/Oct;25(5):e590-e591. doi: 10.1097/MJT.0000000000000602. Am J Ther. 2018. PMID: 28452848 No abstract available.

6

Sodium-glucose cotransporter 2 inhibitors and diabetic ketoacidosis.

Bloomgarden ZT. Bloomgarden ZT. J Diabetes. 2016 Mar;8(2):175-6. doi: 10.1111/1753-0407.12353. Epub 2015 Dec 29. J Diabetes. 2016. PMID: 26611882 No abstract available.

7

Diabetic ketoacidosis associated to canagliflozin in type 2 diabetes.

González Sanchidrián S, Gómez-Martino Arroyo JR, Labrador Gómez PJ. González Sanchidrián S, et al. Med Clin (Barc). 2017 Feb 23;148(4):e19-e20. doi: 10.1016/j.medcli.2016.11.016. Epub 2016 Dec 29. Med Clin (Barc). 2017. PMID: 28041622 English, Spanish. No abstract available.

8

Fanconi syndrome associated with SGLT2 inhibitor, canagliflozin.

Esprit DH, Koratala A. Esprit DH, et al. Nephrology (Carlton). 2018 May;23(5):493. doi: 10.1111/nep.13094. Nephrology (Carlton). 2018. PMID: 29696765 No abstract available.

9

Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor.

Zhang L, Tamilia M. Zhang L, et al. CMAJ. 2018 Jun 25;190(25):E766-E768. doi: 10.1503/cmaj.171319. CMAJ. 2018. PMID: 29941433 Free PMC article. No abstract available.

10

Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report.

Lee IH, Ahn DJ. Lee IH, et al. Medicine (Baltimore). 2020 May 22;99(21):e20228. doi: 10.1097/MD.0000000000020228. Medicine (Baltimore). 2020. PMID: 32481295 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

143 results

Results by year